SNN

Smith & Nephew
NYSE

Real-time Quotes | Nasdaq Last Sale

40.88
-0.28
-0.68%
After Hours: 40.88 0 0.00% 16:00 05/22 EDT
OPEN
40.57
PREV CLOSE
41.16
HIGH
41.22
LOW
40.45
VOLUME
378.76K
TURNOVER
--
52 WEEK HIGH
52.26
52 WEEK LOW
26.07
MARKET CAP
17.88B
P/E (TTM)
29.88
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SNN stock price target is 46.57 with a high estimate of 48.70 and a low estimate of 43.00.

EPS

SNN News

More
Smith+Nephew launches new JOURNEY™ II Unicompartmental Knee System
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of its new JOURNEY II Unicompartmental Knee (UK) System. Built on the heritage of one of the most clinically successful partial knees,1,2 and paired with prop
PR Newswire · 5d ago
Smith+Nephew reports promising early results for new OR3O Dual Mobility System for total hip arthroplasty
PR Newswire · 05/14 13:00
CFRA Maintains Hold on Smith & Nephew, Lowers Price Target to $42
CFRA analyst Wan Nurhayati maintains Smith & Nephew (NYSE:SNN) with a Hold and lowers the price target from $52 to $42.
Benzinga · 05/07 17:43
Smith & Nephew plc (SNN) Q1 2020 Earnings Call Transcript
Motley Fool · 05/06 21:30
Smith+Nephew announces partnership with National Medical Billing Services, a leader in revenue cycle management
PR Newswire · 05/05 13:00
Smith+Nephew partners with Fiagon for distribution of its ENT surgical navigation portfolio in Asia Pacific region
PR Newswire · 05/05 01:00
Stryker: A High-Quality Buy
Seeking Alpha - Article · 03/31 01:23
Raymond James likes Amgen in premarket analyst action
Seeking Alpha - Article · 03/30 12:06

Industry

Medical Equipment, Supplies & Distribution
+0.90%
Healthcare Equipment & Supplies
+1.09%

Hot Stocks

Symbol
Price
%Change

About SNN

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
More

Webull offers kinds of Smith & Nephew plc (ADR) stock information, including NYSE:SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions.